Baseline uptake, % (95% CI)a | 25.7 (22.0 to 28.3) | 24.8 (21.1 to 27.7) | 23.3 (19.2 to 26.4) | 26.2 (23.4 to 32.8) |
|
Change in probability from baseline, % (95% CI)b |
| | | | |
Attribute | Change | | | | |
|
Frequency of BP measurement |
| Monthly to every 3 months | −2.5 (−11.7 to 6.7) | −1.5 (−10.7 to 7.6) | −2.6 (−11.5 to 6.3) | 0.0 (−9.4 to 9.5) |
| Monthly to every 6 months | −4.7 (−13.7 to 4.4) | −4.4 (−13.4 to 4.5) | −3.9 (−12.6 to 4.9) | −1.8 (−11.1 to 7.6) |
| Monthly to every 12 months | −12.7 (−21.0 to 4.3) | −11.9 (−20.2 to 3.6) | −10.9 (−19.0 to 2.8) | −9.5 (−18.2 to 0.7) |
|
Reduction in 5-year cardiovascular risk |
| 5% to 10% | 21.5 (11.5 to 31.6) | 20.9 (10.9 to 30.9) | 20.2 (10.4 to 30.1) | 18.9 (8.8 to 28.9) |
| 5% to 15% | 22.0 (11.9 to 32.0) | 21.9 (11.9 to 31.9) | 19.9 (10.0 to 29.8) | 17.3 (7.3 to 27.4) |
| 5% to 25% | 34.1 (24.2 to 44.1) | 35.1 (25.1 to 45.0) | 34.2 (24.3 to 44.1) | 32.1 (22.1 to 42.1) |
|
Cost to NHS |
| £50 to £100 | −2.9 (−12.1 to 6.3) | −1.1 (−10.3 to 8.1) | −2.8 (−11.7 to 6.0) | −0.3 (−9.7 to 9.1) |
| £50 to £150 | −6.9 (−15.8 to 2.0) | −8.7 (−17.3 to 0.1) | −7.0 (−15.5 to 1.5) | −5.7 (−14.7 to 3.4) |
| £50 to £250 | −14.3 (−22.5 to−6.1) | −13.6 (−21.7 to −5.5) | −14.0 (−21.8 to −6.2) | −10.8 (−19.4 to −2.2) |